Approved PostersView a list of Approved Posters for #SCEH2022 below, in alpha order by first author. Updated: 10/10/2022 Poster Session -- Saturday, October 15, 2022 from 10:45-11:30 AM PT (45 minutes)
Positive Psychology Constructs: Implications for Mindful HypnotherapyVindhya Ekanayake, MS1; Aaron Finley, BA1; Nicholas Olendzki, PsyD1; Gary Elkins, PhD, ABPP, ABPH 1. Background/Rationale: Mindful hypnotherapy (MH) has been developed to deliver mindfulness and positive psychology constructs in the context of hypnotherapy. However, there has been limited research on positive psychology constructs that may be the focus of mindful hypnotherapy suggestions to promote well-being through increased gratitude and hope. You Are Getting Very Sleepy: A Pilot Study Using Clinical Hypnosis to Reduce MRI-Related Anxiety Jeffrey Lee, MD1, Merlin Ariefdjohan, PhD, MPH1, Brittany Seymour, LCSW1, Lindsey McKernan, PhD2, Valeria Potigailo, MD1, Justin Honce, MD1, Alexandra Chadderdon, PsyD3 Background/Purpose: Magnetic resonance imaging (MRI)-related anxiety is a common problem associated with increased patient distress, reduced imaging quality, longer imaging times, repeat imaging, and increased healthcare costs. This study aims to assess the effects of hypnosis (HYP) compared to treatment as usual (TAU) on outcomes of anxiety, service satisfaction, and clinical operations in patients undergoing MRI. Methods: Patients undergoing MRI were randomly assigned to TAU versus HYP groups (n = 10 per group). Patients completed the State and Trait Anxiety Inventory for Adults (STAI-AD) before and after the MRI. Duration of imaging were noted, and two radiologists independently rated the images for motion artifacts to determine MRI quality. After the study, patients rated service satisfaction and were interviewed for additional perspectives. Quantitative data were analyzed using descriptive and inferential statistics, while qualitative responses were summarized as major themes. Results: HYP group exhibited a significant reduction of state anxiety (p = 0.039) but not trait anxiety (p = 0.086). TAU group did not exhibit significant reduction in state nor trait anxiety (p = 0.203, 0.294). HYP group demonstrated significantly lower mean motion artifact scores compared to TAU group (p = 0.009) indicating higher degree of stillness while undergoing MRI. No significant differences were noted in the number of MRI repeats, imaging times, and patient satisfaction scores between HYP vs. TAU groups (p > 0.05 for all). Qualitative interviews indicated satisfaction and openness to the hypnosis procedure in both groups. Conclusion: Our findings suggest that clinical hypnosis is beneficial as an intervention to reduce anxiety and improve imaging quality without a negative impact on clinical operations in patients undergoing MRI. Predicting Hypnotizability and Postoperative Pain Using Single-gene Polymorphisms Jessie Markovits, MD1; Dana L. Cortade, PhD1; Shan X Wang, PhD1; David Spiegel, MD1 Hypnotizability is a longitudinally stable trait that partially moderates the benefit of hypnotic analgesia. Limited availability of practitioners trained in hypnotizability testing can deter widespread use of hypnosis for patients who are uncertain if they will benefit. In this study, an analysis of 4 single nucleotide polymorphisms in the catechol-o-methyltransferase (COMT) gene was performed using inexpensive and efficient giant magnetoresistive biosensors to determine if hypnotizable individuals can be identified using these polymorphisms. Results indicated that 89.5% of individuals with the proposed "optimal" COMT diplotypes score highly on the Hypnotic Induction Profile (OR = 6.12, 95%CI = 1.26-28.75), which identified 40.5% of the treatable population. Mean hypnotizability scores of the optimal group were significantly higher in females (p< 0.002, effect size = 0.83), but not in males (p = 0.28), which may be explained by a known dimorphous effect of sex on COMT activity. An exploratory cohort from the control group of a perioperative pain hypnosis trial showed that optimal individuals reported significantly higher postoperative pain scores (p< 0.001, effect size = 1.93), indicating greatest need for non-pharmacologic pain treatments in this group. Clincialtrials.gov ID: NCT04624880. Hypnotherapy and Cancer Pain in Black/African American Children Johannil Napoleon, MA, LPC, ATR-BC, Adler University In the United States, Black people have a higher cancer rate than non-Blacks; Black children are also more likely to die from cancer than Latinx and White children (American Cancer Society, 2022; Leimanis Laurens et al., 2020). During cancer treatment, 70% of children experience severe pain due to the cancer itself, medical treatments, and procedures used during the illness (Schulte, 2020). Hypnotherapy has been well documented as an effective non-pharmacological intervention used to treat acute and chronic pain and distress related to cancer (e.g., Holroyd, 2002; Milling & Costantino, 2000; Richardson et al., 2006). However, barriers to receiving hypnotherapy services and the unique experiences of Black children managing cancer pain are often overlooked. This poster presentation summarizes key findings from analyzing the published literature on hypnotherapy intervention in pediatric cancer pain and how it relates to Black/African American children. The following will be discussed addressing the topic: experiences of Black children with cancer; cultural factors that impact the expression of pain; the use of hypnotherapy to manage pediatric cancer pain; and benefits and barriers to receiving hypnotherapy in Black children with cancer. Future research and directions in the field of hypnosis will be discussed as they relate to cancer pain in Black children.
|